Academic Journal
Q1Cancer Cell International
About Cancer Cell International
Cancer Cell International is a scholarly journal published by BioMed Central Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.75 and H-index of 100.
Coverage: 2001-2026. Research categories: Genetics (Q1); Oncology (Q1); Cancer Research (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cancer-related molecular mechanisms research; MicroRNA in disease regulation; Ferroptosis and cancer prognosis; Circular RNAs in diseases; Cancer Cells and Metastasis; Cancer Immunotherapy and Biomarkers.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Machine learning-driven single-cell and bulk RNA sequencing integration unveils key genes modulating radiosensitivity and tumor progression in esophageal squamous cell carcinoma
Pengfei Zhang, Ying Zhang, Chen Li, Miao Li et al.
2026-10-02 · DOI: 10.1186/s12935-026-04476-zBulk and single-cell RNA-sequencing analyses along with machine learning methods identify macrophage signatures in colorectal cancer
Ye Wang, Zhicheng Zhuang, Tengyi Peng, Zhen Pan et al.
2026-10-02 · DOI: 10.1186/s12935-026-04445-6Cold atmospheric plasma treated medium (PTM) induce antitumor effects in human ovarian cancer cells
Franziska Keßler, Franziska Oelkrug, Ernst Oberlechner, Jürgen Andress et al.
2026-09-29 · DOI: 10.1186/s12935-026-04461-6Correction: CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions
Duc-Hiep Bach, Van T. Hoang, Pham Thi Viet Huong, Dinh Duy Nguyen et al.
2026-09-28 · DOI: 10.1186/s12935-026-04464-3Metabolic modulators as gatekeepers of immunotherapy response in colorectal cancer
Alireza Najafi, Ali Rahimi, Zeinab Baghernejadian, Ali Hazrati et al.
2026-09-24 · DOI: 10.1186/s12935-026-04471-4The miR105/767 cluster as a coordinator of apoptosis and PD-L1 expression in non-small cell lung cancer
Maryam Abdipourbozorgbaghi, Ramin Radpour, Simon Haefliger
2026-09-22 · DOI: 10.1186/s12935-026-04468-zCharacterizing compounds targeting colorectal cancer derived from monastrol using high-through screening of an extensive combinatorial library
Alejandro Rodríguez-Martínez, Lucía Giraldo-Ruiz, Maria C. Ramos, Irene Luque et al.
2026-09-22 · DOI: 10.1186/s12935-026-04467-0Correction: Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy
Minoo Bakhtiari, Hamid Nickho, Mahmoud Mahmoudi, Fahimeh Lavi Arab et al.
2026-09-22 · DOI: 10.1186/s12935-026-04470-5Canavanine dysregulates cellular signaling and represses ASS1 under arginine deprivation in colorectal carcinoma cells
G. Y. Shuvayeva, Y. P. Bobak, O. I. Chen, O. I. Vovk et al.
2026-09-21 · DOI: 10.1186/s12935-026-04450-9Fibroblast-associated migrasome programs define TSPAN4-driven progression and clinical risk stratification in gastric cancer
Ke Zhang, Feng Ren, Jie Ge, Changhao Huang et al.
2026-09-21 · DOI: 10.1186/s12935-026-04463-4HBX-driven tumor-intrinsic MIF contributes to CD8⁺ T cell exhaustion in HBV-related hepatocellular carcinoma
Qingjian Tan, Kai Wen, Qiaohong Lin, Weida Lin et al.
2026-09-18 · DOI: 10.1186/s12935-026-04469-yEnhanced survival through repeated photodynamic therapy and almost complete tumor regression by prior radiation therapy in an orthotopic rat bladder cancer model
Mandy Berndt-Paetz, Sandra Nürnberger, Susann Gonsior, Ewelina Pączek-Hippe et al.
2026-09-17 · DOI: 10.1186/s12935-026-04465-2Telomerase reverse transcriptase (TERT) accelerates β-catenin-driven hepatocarcinogenesis via MAPK/ERK pathway activation
Hyunjung Park, Jaehun Lee, Hyuk Moon, Simon Weonsang Ro et al.
2026-09-16 · DOI: 10.1186/s12935-026-04329-9Multi-omics analysis of cervical carcinogenesis reveals galectin-9 driven immune evasion as a candidate immunotherapeutic target
Yingqing Deng, Tingting Hu, Youhuang Bai, Dongmei Zhou et al.
2026-09-12 · DOI: 10.1186/s12935-026-04458-1ECT2 antagonizes lipoic acid to modulate papillary thyroid carcinoma progression through energy metabolism pathways
Zhishan Huang, Yingyi Gao, Nan Wang, Dongyan Cai et al.
2026-09-10 · DOI: 10.1186/s12935-026-04459-0SUCLG2 demethylates GADD45G to activate the p53 pathway and inhibit malignant progression in colorectal cancer
Tao Guo, Suhe Lai, Kun Yang, Jin Tong et al.
2026-09-08 · DOI: 10.1186/s12935-026-04454-5The role of RUNX3 in cancer chemoresistance: regulation and therapeutic opportunities
Yanning Gong, Haoyue Deng, Xiongtao Liao, Jianping Zhang et al.
2026-09-08 · DOI: 10.1186/s12935-026-04460-7Decoding the multidimensional regulatory functions of HNRNPC: from RNA metabolism to breakthroughs in multi-disease diagnosis and treatment
Zezhao Ji, Yanbin Peng, Abduxukur Ablimit, Zhiwei Liang et al.
2026-09-08 · DOI: 10.1186/s12935-026-04439-4Immunogenic and systemic antitumor responses induced by photodynamic therapy: a systematic review of the abscopal effect
P. Faghani-Eskandarkolaei, V. Zareei-khooshab, R. Mansouri-Bidekani, H. Heli et al.
2026-09-07 · DOI: 10.1186/s12935-026-04455-4MED1 in cancer: a context-dependent transcriptional regulator
Zhe Li, Zhaosong Meng, Lei Sui, Chufan Ma et al.
2026-09-07 · DOI: 10.1186/s12935-026-04457-2Reviews
Community Reviews
Version History
September 25, 2026 at 7:19 am
September 25, 2026